HealthTech - Informa Connect (@HealthTechIC) header
HealthTech - Informa Connect (@HealthTechIC) profile picture

Cutting edge events and insight about the convergence of technology and medicine from Informa Connect, including #mhealth, #AI, #IoMT & #Digital medicine

London
Joined December 2019
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
1
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
1
1
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
1
1
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…